Hospital
Miners Colfax Medical Center
Miners Colfax Medical Center was paid $9.09M by Medicaid between Jan 2018 and Dec 2024, across 141 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoMINERS COLFAX MEDICAL CENTER
RATON, NM 87740
RATON, NM 87740
33aNPI1083931109assigned 04/29/2010
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$9.09M
24GClaims143,481
24DCodes billed141
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,982 | $1.32M | |
| 2019 | 19,343 | $1.04M | |
| 2020 | 13,894 | $734K | |
| 2021 | 14,532 | $846K | |
| 2022 | 18,437 | $1.32M | |
| 2023 | 26,662 | $2.09M | |
| 2024incomplete | 22,631 | $1.74M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 12,263 | 10,690 | $2.09M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 4,860 | 4,293 | $1.40M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.1% | 2,273 | 1,897 | $823K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.8% | 12,381 | 11,425 | $524K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.4% | 8,115 | 7,415 | $487K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.5% | 4,239 | 4,198 | $225K |
| 76820 | 2.3% | 1,297 | 807 | $206K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.9% | 365 | 316 | $176K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.9% | 969 | 937 | $175K |
| 76819 | Fetal biophysical profile; without non-stress testing | 1.8% | 987 | 623 | $165K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 2,072 | 1,796 | $145K |
| 80053 | Comprehensive metabolic panel | 1.5% | 7,928 | 6,768 | $138K |
129 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 1,076 | $135K |
| 90461 | 1.4% | 1,764 | $131K | |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.3% | 2,350 | $122K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.3% | 2,486 | $117K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 2,196 | $110K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.2% | 623 | $106K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 14,044 | $104K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 9,777 | $104K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 1,358 | $100K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 471 | $86K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 749 | $84K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,401 | $84K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,355 | $82K |
| G0378 | Hospital observation service, per hour | <1% | 93 | $75K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 329 | $70K |
| J3490 | Unclassified drugs | <1% | 7,103 | $63K |
| 87631 | <1% | 378 | $61K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,304 | $54K |
| 71045 | Radiologic examination, chest; single view | <1% | 872 | $53K |
| 80306 | <1% | 1,683 | $52K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 545 | $40K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,005 | $39K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 368 | $29K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,217 | $29K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 188 | $27K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 551 | $27K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 410 | $26K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,928 | $26K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 489 | $23K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 417 | $22K |
| 80061 | Lipid panel | <1% | 1,279 | $22K |
| 83605 | <1% | 1,266 | $21K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 347 | $21K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 159 | $20K |
| 81003 | <1% | 3,776 | $20K | |
| 87428 | <1% | 184 | $19K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,444 | $17K |
| 90686 | <1% | 897 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 643 | $16K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 80 | $16K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 497 | $16K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 94 | $13K |
| 83690 | <1% | 1,159 | $13K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 184 | $13K |
| 84484 | <1% | 925 | $11K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 292 | $10K |
| 80050 | General health panel | <1% | 272 | $9K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 83 | $9K |
| 84439 | <1% | 750 | $9K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 15 | $9K |
| 81025 | <1% | 678 | $8K | |
| 0002A | <1% | 200 | $8K | |
| 83735 | <1% | 921 | $8K | |
| 0001A | <1% | 207 | $8K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,198 | $7K |
| 87641 | <1% | 131 | $7K | |
| 83655 | <1% | 169 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 419 | $6K |
| 84702 | <1% | 204 | $5K | |
| 87400 | <1% | 212 | $4K | |
| 81001 | <1% | 1,042 | $4K | |
| 90656 | <1% | 178 | $4K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 14 | $4K |
| 91300 | <1% | 393 | $4K | |
| 83880 | <1% | 78 | $3K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 177 | $3K |
| 72110 | <1% | 25 | $3K | |
| 73610 | <1% | 26 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 614 | $3K |
| 86780 | <1% | 122 | $3K | |
| 85610 | <1% | 470 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 38 | $3K |
| 99173 | <1% | 75 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 44 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 17 | $2K |
| 36416 | <1% | 82 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 212 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 414 | $2K |
| 90723 | <1% | 70 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 419 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $2K |
| 73562 | <1% | 18 | $2K | |
| 82150 | <1% | 171 | $2K | |
| 99443 | <1% | 14 | $2K | |
| 73030 | <1% | 13 | $2K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 48 | $1K |
| 87480 | <1% | 40 | $1K | |
| 87510 | <1% | 40 | $1K | |
| 86703 | <1% | 53 | $1K | |
| 87660 | <1% | 40 | $1K | |
| 86850 | <1% | 84 | $1K | |
| 86900 | <1% | 63 | $1K | |
| 85379 | <1% | 56 | $935.60 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $906.88 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 224 | $868.36 |
| 88738 | <1% | 74 | $829.26 | |
| 82607 | <1% | 49 | $809.67 | |
| 85378 | <1% | 60 | $805.71 | |
| 85730 | <1% | 77 | $775.90 | |
| 87430 | <1% | 35 | $775.73 | |
| 87340 | <1% | 41 | $758.34 | |
| 85652 | <1% | 172 | $748.37 | |
| 82550 | <1% | 58 | $610.27 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 153 | $607.78 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $559.26 |
| 86901 | <1% | 65 | $554.28 | |
| 0003A | <1% | 13 | $520.09 | |
| 86141 | <1% | 15 | $518.42 | |
| 86803 | <1% | 14 | $517.01 | |
| 85018 | <1% | 55 | $502.85 | |
| G0008 | Administration of influenza virus vaccine | <1% | 94 | $417.21 |
| 87807 | <1% | 17 | $406.69 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | <1% | 60 | $392.77 |
| 82553 | <1% | 19 | $389.46 | |
| 84481 | <1% | 14 | $353.96 | |
| 80320 | <1% | 63 | $289.86 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 24 | $276.70 |
| 87040 | <1% | 14 | $246.38 | |
| 85048 | <1% | 58 | $167.64 | |
| 90677 | <1% | 63 | $158.29 | |
| 84100 | <1% | 27 | $156.78 | |
| J2704 | Injection, propofol, 10 mg | <1% | 12 | $130.55 |
| 86140 | <1% | 14 | $87.06 | |
| 90670 | <1% | 427 | $83.57 | |
| 90688 | <1% | 135 | $81.68 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 14 | $43.59 |
| 90685 | <1% | 79 | $34.40 | |
| 90680 | <1% | 53 | $0.23 | |
| 90647 | <1% | 36 | $0.18 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROLAND, BRIAN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Hamilton County Hospital District | Hamilton, TX | $1.46M |
| Kiowa County Hospital Authority | Hobart, OK | $1.42M |
| Hamilton County Hospital District | Goldthwaite, TX | $604K |
| Kiowa County Hospital Authority | Hobart, OK | $430K |
| Stephens Memorial Hospital District | Mabank, TX | $322.14 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.